Please login to the form below

‘How-to’ guide: Successful patient support programmes

Breaking down the steps to success into 10 bite-size chunks
The patient journey has been under increased scrutiny over the last few years. How are patients identified? What happens at the point of diagnosis and, most crucially, what happens after they leave with prescription in hand? Pharmaceutical companies have asked these same questions, and have also asked themselves how they can innovate to support and care more for patients. This is evident today with the rise of 'patient support programmes’ (PSPs): pharma’s answer to the challenge of delivering increased patient centricity.

Ashfield has a wealth of expertise in this field. We ensure that PSPs are not only effective and provide value back to patients and healthcare organisations, but that they are also operationally robust with our local knowledge of governance and regulations.

Designing and operating a PSP can be complex and challenging. We partner with clients, utilising our knowledge in this field, to make PSPs seamless and to deliver improved patient outcomes. If you’re considering a PSP or how to improve your patients' experience through treatment, we have created a short guide to our considerations of a successful programme. From initial concepts and regulation considerations, through to record keeping and stakeholder management, we hope our guide shows that the world of PSPs can provide an abundance of value back to patients, healthcare companies and to pharma.

Read our ‘10 steps to a successful patient support programme’ guide.

This article has been published by Ashfield Clinical.

4th August 2016



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield’s highlights from eyeforpharma Barcelona 2018
This week we were delighted to attend eyeforpharma Barcelona 2018 as global sponsors, where we ran a communications strategy workshop using our new Humanise framework and Nagore Fernandez, Head of Clinical Services for EUCAN, hosted part of the Commercial track.
Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.